Loading clinical trials...
Loading clinical trials...
SATIN: Satiety Innovation, Study 2. Effect of Novel Fibres (Arabinoxylan and Beta-glucan) in Appetite, Metabolic and Gut Health.
Conditions
Interventions
Arabinoxylan
Beta- Glucan
Locations
1
United Kingdom
Rowett Institute of Nutrition and Health. University of Aberdeen
Aberdeen, United Kingdom
Start Date
January 1, 2014
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
May 4, 2017
NCT06277232
NCT07395973
NCT05301413
NCT05796141
NCT06487832
NCT06076187
Lead Sponsor
University of Aberdeen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions